Liraglutide improves vascular dysfunction by regulating a cAMP-independent PKA-AMPK pathway in perivascular adipose tissue in obese mice
Author contributions AK: Writing original draft, Writing review & editing
doi:10.4236/ijcm.2012.33034 Richardson J
These medications have clear data on long-term effects, including sustained weight loss, improved metabolic markers, and tolerability patterns
Which condition is caused by excessive melanin
Pan-HDAC inhibitors lack isoform specificity and may induce cytotoxicity or even cardiotoxicity (e.g., QT prolongation) at high doses, and currently, no HDACi is approved specifically for cardiovascular indications 156,168